Answers are grounded in this paper and cite their sources.
A biofunctional organic–inorganic nanocomposite comprising mesoporous silica-coated single-walled carbon nanotubes (SWCNTs) and ferulic acid-mediated silver nanoparticles (FERA-AgNPs) was developed and evaluated for its in vitro cytotoxic activity against HL-60 leukemia cells. Mesoporous silica was deposited on SWCNTs using a CTAB-assisted sol–gel method, followed by incorporation of AgNPs synthesized through ferulic acid–assisted reduction. The resulting FERA–Ag–Meso–Si–SWCNT nanocomposite exhibited Z-average hydrodynamic diameter of 190.2 nm and a zeta potential of –26.6 mV, with uniform tubular networks confirmed by SEM and TEM. XRD analysis indicated crystalline, AgNP domains, while thermal studies demonstrated stability up to 150 °C. High entrapment efficiency (77.19 ± 1.25%) and drug-loading capacity (9.45 ± 0.75%) verified efficient FERA incorporation. In vitro cytotoxicity against HL-60 leukemia cells revealed enhanced anticancer activity (IC₅₀ = 59.75 µg/mL) compared to free FERA (IC₅₀ = 65.26 µg/mL). The study highlights a leukemia-oriented nanocomposite comprising SWCNTs, mesoporous silica, AgNPs, and ferulic acid, evaluating its in vitro cytotoxic activity against HL-60 leukemia cells.
No takes yet. Share an insight, caveat, or question.
Yadav et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: